Syneika provides doctors with a targeting solution that is both reliable and reproducible, based on MRI imaging, allowing each patient to benefit from an individualised treatment. The Syneika neuronavigator uses innovative technologies to automatically prepare data in just minutes. Developed with doctors, its simplicity and ergonomics make it a particularly well suited neuronavigation solution for daily clinical practice. Syneika offers an efficient and cost-effective neuronavigator that improves reproducibility and Transcranial Magnetic Stimulation, or TMS, conditions of therapeutic use. |
| Depression affects 5 to 10% of the population. It is the world's leading cause of disability. Source : World Health OrganisationWithout reliable targeting, two depressed patients in three are not correctly stimulated in the therapeutic site. Source : Herwig et al., 2001Precise targeting of the target site improves the therapeutic efficiency of the TMS on treatment-resistant depression. Source : Fitzgerald et al. 2009 |
